These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 36523986)

  • 41. Human Microbiota and Personalized Cancer Treatments: Role of Commensal Microbes in Treatment Outcomes for Cancer Patients.
    Gately S
    Cancer Treat Res; 2019; 178():253-264. PubMed ID: 31209849
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Gut microbiota and immune crosstalk in metabolic disease].
    Burcelin R
    Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The gut microbiome and cancer immunotherapeutics: A review of emerging data and implications for future gynecologic cancer research.
    McKenzie ND; Hong H; Ahmad S; Holloway RW
    Crit Rev Oncol Hematol; 2021 Jan; 157():103165. PubMed ID: 33227575
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cancer and the Microbiome-Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy.
    Matson V; Chervin CS; Gajewski TF
    Gastroenterology; 2021 Jan; 160(2):600-613. PubMed ID: 33253684
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Unexpected guests in the tumor microenvironment: microbiome in cancer.
    Wong-Rolle A; Wei HK; Zhao C; Jin C
    Protein Cell; 2021 May; 12(5):426-435. PubMed ID: 33296049
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Microbiome as a Component of the Tumor Microenvironment.
    Kovács T; Mikó E; Ujlaki G; Sári Z; Bai P
    Adv Exp Med Biol; 2020; 1225():137-153. PubMed ID: 32030653
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Compartmentalization of the host microbiome: how tumor microbiota shapes checkpoint immunotherapy outcome and offers therapeutic prospects.
    Boesch M; Horvath L; Baty F; Pircher A; Wolf D; Spahn S; Straussman R; Tilg H; Brutsche MH
    J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36343977
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of intratumoral microbiota on tumorigenesis, anti-tumor immunity, and microbe-based cancer therapy.
    Zheng J; Chen H
    Front Oncol; 2024; 14():1429722. PubMed ID: 39391251
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Understanding the role of the gut microbiome in gastrointestinal cancer: A review.
    Ağagündüz D; Cocozza E; Cemali Ö; Bayazıt AD; Nanì MF; Cerqua I; Morgillo F; Saygılı SK; Berni Canani R; Amero P; Capasso R
    Front Pharmacol; 2023; 14():1130562. PubMed ID: 36762108
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The gut microbiome and melanoma: A review.
    Makaranka S; Scutt F; Frixou M; Wensley KE; Sharma R; Greenhowe J
    Exp Dermatol; 2022 Sep; 31(9):1292-1301. PubMed ID: 35793428
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Microenvironment-driven intratumoral heterogeneity in head and neck cancers: clinical challenges and opportunities for precision medicine.
    Van den Bossche V; Zaryouh H; Vara-Messler M; Vignau J; Machiels JP; Wouters A; Schmitz S; Corbet C
    Drug Resist Updat; 2022 Jan; 60():100806. PubMed ID: 35121337
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Microbiota regulates intratumoral monocytes to promote anti-tumor immune responses.
    McCoy KD; Geuking MB
    Cell; 2021 Oct; 184(21):5301-5303. PubMed ID: 34624223
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synergistic Target of Intratumoral Microbiome and Tumor by Metronidazole-Fluorouridine Nanoparticles.
    Gao C; Wang X; Yang B; Yuan W; Huang W; Wu G; Ma J
    ACS Nano; 2023 Apr; 17(8):7335-7351. PubMed ID: 37036121
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interplay between Dysbiosis of Gut Microbiome, Lipid Metabolism, and Tumorigenesis: Can Gut Dysbiosis Stand as a Prognostic Marker in Cancer?
    Chattopadhyay I; Gundamaraju R; Jha NK; Gupta PK; Dey A; Mandal CC; Ford BM
    Dis Markers; 2022; 2022():2941248. PubMed ID: 35178126
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Concepts Collide: Genomic, Immune, and Microbial Influences on the Tumor Microenvironment and Response to Cancer Therapy.
    Andrews MC; Reuben A; Gopalakrishnan V; Wargo JA
    Front Immunol; 2018; 9():946. PubMed ID: 29780391
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The role of intestinal macrophages and the enteric nervous system in gut neuroimmunology. Basic science and clinical implications].
    Dóra D; Kovács T; Nagy N
    Orv Hetil; 2020 May; 161(19):771-779. PubMed ID: 32364357
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The updated landscape of tumor microenvironment and drug repurposing.
    Jin MZ; Jin WL
    Signal Transduct Target Ther; 2020 Aug; 5(1):166. PubMed ID: 32843638
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The impact of the human microbiome in tumorigenesis, cancer progression, and biotherapeutic development.
    Doocey CM; Finn K; Murphy C; Guinane CM
    BMC Microbiol; 2022 Feb; 22(1):53. PubMed ID: 35151278
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diet and gut microbiome interactions in gynecologic cancer.
    AlHilli MM; Bae-Jump V
    Gynecol Oncol; 2020 Nov; 159(2):299-308. PubMed ID: 32933758
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Crosstalk between the Gut Microbiome and Colonic Motility in Chronic Constipation: Potential Mechanisms and Microbiota Modulation.
    Pan R; Wang L; Xu X; Chen Y; Wang H; Wang G; Zhao J; Chen W
    Nutrients; 2022 Sep; 14(18):. PubMed ID: 36145079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.